PRISMASOL BGK0/2.5 5.4 g/L (Calcium Chloride, Magnesium Chloride, Dextrose Anhydrous, Lactic Acid, Sodium Chloride, and Sodium B INJECTION) 5.4 g/L

PRISMASOL BGK0/2.5 5.4 g/L is an intravenous injection containing calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, and sodium bicarbonate. It is designed to support electrolyte balance and fluid replacement in medical settings. This product is manufactured by Vantive US Healthcare LLC in the USA.

Strength

5.4 g/L

Pack Size

2 BAG in 1 CASE (24571-108-06) / 5 L in 1 BAG

Manufacturer / TM Owner

Vantive US Healthcare LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PRISMASOL BGK0/2.5 5.4 g/L is used for intravenous fluid and electrolyte replacement. It provides essential electrolytes and dextrose to help maintain proper fluid balance and support metabolic processes. This solution is often used in clinical settings to address deficiencies or imbalances in electrolytes, which can occur due to various medical conditions or treatments.

Side Effects

The effects of PRISMASOL BGK0/2.5 5.4 g/L are primarily related to the restoration and maintenance of electrolyte levels in the body. Patients may experience improved hydration and electrolyte balance, which can support overall health and well-being. As with any medical product, individual responses may vary.

Precautions & Warnings

PRISMASOL BGK0/2.5 5.4 g/L should be administered under the supervision of a healthcare professional. It is important to follow proper handling and storage guidelines to ensure the product's efficacy and safety. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

PRISMASOL BGK0/2.5 5.4 g/L may interact with other medications or substances. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of this product.

Frequently Asked Questions

PRISMASOL BGK0/2.5 5.4 g/L is used for intravenous fluid and electrolyte replacement to support proper fluid balance and metabolic processes.

PRISMASOL BGK0/2.5 5.4 g/L is administered intravenously and should be done under the supervision of a healthcare professional.

The common effects include improved hydration and electrolyte balance, supporting overall health and well-being.

Yes, it should be administered under the supervision of a healthcare professional, and proper handling and storage guidelines should be followed.

Yes, it may interact with other medications or substances, so it is important to inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.